drugset / Trial / NCT01707381
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
RandomizedCrossoverOpen-labelTreatment
Summary
This clinical investigation is being performed to compare the effect of BOL-303259-X dosed once daily (QD) with timolol maleate 0.5% dosed twice daily (BID) in reducing intraocular pressure (IOP) measured over a 24-hour period in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Timeline
- Start
- 2012-11
- Primary completion
- 2013-12
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latanoprostene bunod | Small molecule | 0.024 % | Topical |
| Comparator | Timolol | Other / unclassified | 0.5 % | Topical |